372 related articles for article (PubMed ID: 947647)
1. Primary immune response to Helix pomatia haemocyanin in malignant melanoma. Relationship between 19S and 7S antibody response and in vitro lymphocyte transformation.
Gast GC; The TH; Schraffordt Koops H; Snijder AM; Huiges HA
Clin Exp Immunol; 1976 Mar; 23(3):491-8. PubMed ID: 947647
[TBL] [Abstract][Full Text] [Related]
2. Immune response in asymptomatic paraproteinemia. I. Primary and secondary antibody response to Helix pomatia hemocyanin.
Weits J; de Gast GC; The TH; Marrink J; Mandema E
Scand J Immunol; 1976; 5(10):1163-71. PubMed ID: 1013650
[TBL] [Abstract][Full Text] [Related]
3. Class-specific antibody titres (ELISA) against the primary immunogen Helix pomatia haemocyanin (HPH) in man.
Weits J; de Gast GC; The TH; Esselink MT; Deelder AM; Petrovic M; Mandema E
Clin Exp Immunol; 1978 Jun; 32(3):443-50. PubMed ID: 80296
[TBL] [Abstract][Full Text] [Related]
4. The primary immune response in patients with selective IgA deficiency.
De Graeff PA; The TH; van Munster PJ; Out TA; Vossen JM; Zegers BJ
Clin Exp Immunol; 1983 Dec; 54(3):778-84. PubMed ID: 6652975
[TBL] [Abstract][Full Text] [Related]
5. The primary immune response of patients with different stages of squamous-cell bronchial carcinoma.
Jansen HM; The TH; de Gast GC; Esselink MT; Pastoor G; Orie NG
Thorax; 1978 Dec; 33(6):755-60. PubMed ID: 746500
[TBL] [Abstract][Full Text] [Related]
6. Class- and subclass-specific antibody response to hemocyanin in nonmalignant paraproteinemia.
Weits J; de Gast GC; The TH; Esselink MT; van der Giessen M; Mandema E
J Lab Clin Med; 1979 Sep; 94(3):458-66. PubMed ID: 469381
[TBL] [Abstract][Full Text] [Related]
7. Antibody responses in vivo in chromosome instability syndromes with immunodeficiency.
Weemaes CM; The TH; van Munster PJ; Bakkeren JA
Clin Exp Immunol; 1984 Sep; 57(3):529-34. PubMed ID: 6467678
[TBL] [Abstract][Full Text] [Related]
8. In vitro lymphocyte reactivity and T cell levels in patients with melanoma: correlations with clinical and pathological stage.
Silverman NA; Alexander JC; Potvin C; Chretien PB
Surgery; 1976 Mar; 79(3):332-9. PubMed ID: 1083075
[TBL] [Abstract][Full Text] [Related]
9. [Immune profil in melanoma patients. III. Behavior of immunglobulins (IgG, IgA, IgM) and of whole complement in serum at the beginning and during BCG-therapy (author's transl)].
Knopf B; Wätzig V; Stelzner A
Arch Geschwulstforsch; 1979; 49(4):299-304. PubMed ID: 496567
[TBL] [Abstract][Full Text] [Related]
10. A prospective study of lymphocyte responses to phytohemagglutinin in melanoma patients. (lack o prognostic value of correlation with minimal tumor burden).
Kovarík J; Ninger E; Zemanová D; Lauerová L
Neoplasma; 1980; 27(5):575-82. PubMed ID: 7231613
[TBL] [Abstract][Full Text] [Related]
11. The primary immune response in bronchial asthma. I. A kinetic study of Helix pomatia hemocyanin-specific IgE, IgG, IgA, and IgM antibody responses in patients with asthma and in matched controls.
Weller FR; Kallenberg CG; Jansen HM; Torensma R; Klaassen RJ; Weller HH; Orie NG; The TH
J Allergy Clin Immunol; 1985 Jul; 76(1):29-34. PubMed ID: 4008812
[TBL] [Abstract][Full Text] [Related]
12. B cell activity in systemic lupus erythematosus: depressed in vivo humoral immune response to a primary antigen (haemocyanin) and increased in vitro spontaneous immunoglobulin synthesis.
Kallenberg CG; Limburg PC; Van Slochteren C; Van der Woude FJ; The TH
Clin Exp Immunol; 1983 Aug; 53(2):371-83. PubMed ID: 6192955
[TBL] [Abstract][Full Text] [Related]
13. Induction of antibodies against GM2 ganglioside by immunizing melanoma patients using GM2-keyhole limpet hemocyanin + QS21 vaccine: a dose-response study.
Chapman PB; Morrissey DM; Panageas KS; Hamilton WB; Zhan C; Destro AN; Williams L; Israel RJ; Livingston PO
Clin Cancer Res; 2000 Mar; 6(3):874-9. PubMed ID: 10741710
[TBL] [Abstract][Full Text] [Related]
14. Antibody responses in melanoma patients immunized with an anti-idiotype antibody mimicking disialoganglioside GD2.
Foon KA; Sen G; Hutchins L; Kashala OL; Baral R; Banerjee M; Chakraborty M; Garrison J; Reisfeld RA; Bhattacharya-Chatterjee M
Clin Cancer Res; 1998 May; 4(5):1117-24. PubMed ID: 9607568
[TBL] [Abstract][Full Text] [Related]
15. [Secretion of immunoglobulins in malignant melanoma of the skin].
Babakova SV; Kuznetsov VA; Gorodilova VV; Konradov AA; Chervonnaia LV
Vopr Onkol; 1988; 34(3):314-8. PubMed ID: 3358294
[TBL] [Abstract][Full Text] [Related]
16. Serologic changes following B lymphocyte depletion therapy for rheumatoid arthritis.
Cambridge G; Leandro MJ; Edwards JC; Ehrenstein MR; Salden M; Bodman-Smith M; Webster AD
Arthritis Rheum; 2003 Aug; 48(8):2146-54. PubMed ID: 12905467
[TBL] [Abstract][Full Text] [Related]
17. Humoral immune response to intralymphatic immunotherapy for disseminated melanoma: correlation with clinical response.
Ahn SS; Irie RF; Weisenburger TH; Jones PC; Juillard G; Roe DJ; Morton DL
Surgery; 1982 Aug; 92(2):362-7. PubMed ID: 7101129
[TBL] [Abstract][Full Text] [Related]
18. Endogenous immune response to early- and intermediate-stage melanoma is correlated with outcomes and is independent of locoregional relapse and standard prognostic factors.
Litvak DA; Gupta RK; Yee R; Wanek LA; Ye W; Morton DL
J Am Coll Surg; 2004 Jan; 198(1):27-35. PubMed ID: 14698308
[TBL] [Abstract][Full Text] [Related]
19. Humoral and cell-mediated immune response in patients with malignant melanoma. I. In vitro lymphocyte reactivity to PHA and antigens following immunization.
de Gast GC; The TH; Schraffordt Koops H; Huiges HA; Oldhoff J; Nieweg HO
Cancer; 1975 Oct; 36(4):1289-97. PubMed ID: 1175127
[TBL] [Abstract][Full Text] [Related]
20. Primary cell-mediated immune response in bronchial asthma. Relationship between primary in vitro and in vivo cell-mediated and antibody responses in patients with asthma and healthy controls.
Weller FR; Kallenberg CG; Orie NG; Weller HH; Jansen HM; The TH
Clin Allergy; 1986 May; 16(3):241-50. PubMed ID: 3719936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
